Having a Business Continuity Plan (BCP) would have enabled many companies to cope much better with the crisis linked to the COVID-19.Indeed, the Business Continuity Plan (BCP) makes it possible to anticipate problems likely the di

The Qualified Person (QP) a key function in the French pharmaceutical companies The Qualified Person is a privileged function in France. Placed at the heart of the board of directors of the French pharmaceutica

Falsified medicines may contain ingredients of bad or toxic quality, or in the wrong ingredient or the wrong dosage. They represent a serious risk to public health that is the reason why the European Union (EU) put in place a comp

Every year, the European Medicines Agency (EMA) adjusts its fees on 1 April, in line with the European Union (EU) inflation rate for the previous year.On 1 April 2018 general, non-pharmacovigilance fees payable to E

Regulation (EU) 2016/679, the European Union’s (EU) new General Data Protection Regulation regulates the processing by an individual, a company or an organisation of personal data relating to individuals in the EU. This regulation